Literature DB >> 15648557

Hemostasis and thyroid diseases revisited.

M Franchini1.   

Abstract

Several papers have reported various hemostatic abnormalities in patients with thyroid diseases. In this concise review, the traditional associations between hypercoagulable state and hyperthyroidism and between hypocoagulative state and hypothyroidism are critically revised on the basis of more recent literature data. In particular, we analyze the hemostatic balance (primary hemostasis, coagulation factors and fibrinolytic system) in different thyroid disorders. Although most of the studies published so far include limited numbers of patients and their results are sometimes contradictory, we can conclude that hyperthyroidism is generally accompanied by a hypercoagulable state, whereas the hemostatic profile in hypothyroidism and thyroid cancer depends on the severity of the disease.

Entities:  

Mesh:

Year:  2004        PMID: 15648557     DOI: 10.1007/BF03346287

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  85 in total

1.  Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family.

Authors:  V De Stefano; G Leone; L Teofili; L De Marinis; P Micalizzi; C Fiumara; B Bizzi
Journal:  Thromb Res       Date:  1990-12-01       Impact factor: 3.944

2.  Acquired haemophilia in association with organ-specific autoimmune disease.

Authors:  D J Meiklejohn; H G Watson
Journal:  Haemophilia       Date:  2001-09       Impact factor: 4.287

Review 3.  Acquired von Willebrand syndrome--report of 10 cases and review of the literature.

Authors:  I C Nitu-Whalley; C A Lee
Journal:  Haemophilia       Date:  1999-09       Impact factor: 4.287

4.  Variable presentation of thrombocytopenia in Graves' disease.

Authors:  A Adrouny; R M Sandler; R Carmel
Journal:  Arch Intern Med       Date:  1982-08

5.  Haemostatic and lipid abnormalities in hypothyroidism.

Authors:  A Nordoy; H Vik-Mo; H Berntsen
Journal:  Scand J Haematol       Date:  1976-02

6.  Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes?

Authors:  I Cordiano; C Betterle; C A Spadaccino; B Soini; A Girolami; F Fabris
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody.

Authors:  F Marongiu; C Cauli; G Mameli; B Usai; S Mariotti
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

8.  Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol.

Authors:  J Burggraaf; S Lalezari; J J Emeis; U M Vischer; P H de Meyer; H Pijl; A F Cohen
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

9.  Activation of blood coagulation and fibrinolysis in Graves' disease.

Authors:  F Marongiu; M Conti; M L Murtas; G Mameli; G G Sorano; E Martino
Journal:  Horm Metab Res       Date:  1991-12       Impact factor: 2.936

10.  Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man.

Authors:  A T van Oosterom; P Kerkhoven; J J Veltkamp
Journal:  Thromb Haemost       Date:  1979-04-23       Impact factor: 5.249

View more
  9 in total

1.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

Review 2.  Thyroid-associated autoimmune coagulation disorders.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato; Pier Paolo Vescovi
Journal:  J Thromb Thrombolysis       Date:  2009-03-10       Impact factor: 2.300

3.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

4.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 5.  Coagulation and fibrinolysis in thyroid dysfunction.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

Review 6.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

7.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.

Authors:  Bülent Alioğlu; Nevin Kılıç; Enver Şimşek; Yıldız Dallar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09

Review 8.  Hemostasis in Overt and Subclinical Hyperthyroidism.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-04-23

9.  Thyroid Diseases Are an Underestimated Risk Factor for Cerebral Venous Sinus Thrombosis.

Authors:  Maren Hieber; Charlotte von Kageneck; Cornelius Weiller; Johann Lambeck
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.